AI assistant
Sending…
GENTEX CORP — Director's Dealing 2020
Nov 20, 2020
30893_dirs_2020-11-20_86501215-7968-4e0d-8819-7e78a8ec3855.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2020-11-18
Reporting Person: Nash Kevin C (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-18 | Common Stock | M | 4836.00 | $15.50 | Acquired | 34876.00 | Direct |
| 2020-11-18 | Common Stock | M | 5864.00 | $13.385 | Acquired | 40740.00 | Direct |
| 2020-11-18 | Common Stock | S | 10700.00 | $33.1814 | Disposed | 30040.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-18 | Employee Stock Option (Right to buy) | $15.50 | M | 4836.00 | Disposed | 2022-09-30 | Common Stock (4836.00) | Direct |
| 2020-11-18 | Employee Stock Option (Right to buy) | $13.385 | M | 5864.00 | Disposed | 2021-09-30 | Common Stock (5864.00) | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $33.10 to $33.30. The price reported above reflects the weighted average price.
F3: Options are fully vested.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19